Get the app
NSEHealthcare

Innova Captab Limited (INNOVACAP)

NSE · Healthcare · Drug Manufacturers - Specialty & Generic

₹1,149.50+1.42%
Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue
₹471 cr
Revenue YoY
+33.9%
Net profit
₹44 cr
Profit YoY
+42.3%
EPS
₹7.71
EPS estimate
₹3.40
Net margin
9.4%

EPS came in at 7.71 against a street estimate of 3.40 — a beat of 126.8%.

Key statistics

Market cap
₹6,373 cr
P/E
41.3
Forward P/E
0.0
P/B
6.02
Book value
₹190.62
EPS (TTM)
₹26.96
52-week high
₹1,236.10
52-week low
₹622.00
50-day MA
₹1,025.06
200-day MA
₹825.40
Beta
-0.01

Analyst view

with an average price target of ₹1,116.00.

Shareholding

Promoters
72.19%
Institutions
18.97%

Recent filings & reports

DocumentDate
Annual report FY2026
INNOVA CAPTAB LIMITED – ANNUAL REPORT FY 2025-26 HEADLINE NUMBERS • Market capitalization as on 31 March 2026: ₹3,948 crores • Revenue from operatio
2026-09-04
Quarterly results · Q1 FY27
INNOVA CAPTAB LIMITED – SUMMARY FOR RETAIL INVESTORS HEADLINE NUMBERS • Full Year FY2025-26 Revenue: ₹16,300.18 million (vs ₹12,436.76 million in FY
2026-08-22
Q1 FY27 earnings call
INNOVA CAPTAB LIMITED – Q1 FY27 EARNINGS SUMMARY HEADLINE NUMBERS • Consolidated Revenue: INR 470.9 crores in Q1 FY27, up 34% year-on-year • EBITDA:
2026-08-14
Investor presentation · Q1 FY27
INNOVA CAPTAB LIMITED – INVESTOR SUMMARY HEADLINE NUMBERS • Q1 FY27 Revenue: ₹470.9 crore, up 34% YoY (vs. ₹351.5 crore in Q1 FY26) • Q1 FY27 EBITDA
2026-08-11
Annual report FY2026
INNOVA CAPTAB LIMITED - ANNUAL REPORT FY 2025-26 SUMMARY HEADLINE NUMBERS • Market Capitalization: ₹3,948 Crores as of 31 March 2026 • Revenue from
2026-06-04
Q4 FY26 earnings call
INNOVA CAPTAB LIMITED – EARNINGS CALL SUMMARY HEADLINE NUMBERS • FY '26 Total Revenue: INR 1,630 crores – 31% year-on-year growth; highest ever annu
2026-05-14
Quarterly results · Q4 FY26
INNOVA CAPTAB LIMITED – FINANCIAL SUMMARY HEADLINE NUMBERS • FY 2025-26 Revenue from Operations: ₹16,300.18 million (vs ₹12,456.76 million in FY 202
2026-05-07
Investor presentation
INNOVA CAPTAB LIMITED – INVESTOR SUMMARY HEADLINE NUMBERS • Revenue FY26: ₹1,630 crore (31% YoY growth; Q4 FY26: ₹447.8 crore, +42% YoY) • EBITDA FY
2026-05-07

Readable in the app.

Corporate actions

ActionDetailDate
Dividend₹2 / share
ex-date Jan 30, 2026
2026-01-30

Deals & corporate news

AnnouncementDate
Capacity addition announced
Innova Captab Limited announced on August 22, 2026 that its Board approved revised audited financial results for the year ended March 31, 2026. The company has restated its financial stateme
2026-08-22
Interim dividend of Rs. 2 per equity share declared
Innova Captab Limited's Board of Directors declared an interim dividend of Rs. 2 per equity share on January 23, 2026. This means each shareholder will receive Rs. 2 for every share they own
2026-01-23

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Innova Captab Limited — free to start.

Google PlayApp Store

Other Healthcare companies

Data updated 2026-09-18.